Trade Mark Journal No.2025/021 23 May 2025

UK00004195603 28 April 2025 (40,42)

DAR-T

International priority date claimed: 18 November 2024 (United States of America) (98858205)

Class 40: Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing platform for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology.
Class 42: Consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins.

National Resilience, Inc

Representative: CMS Cameron McKenna Nabarro Olswang LLP